Status: Not yet recruiting
A Trial to Evaluate KPC000154 Tablets in Healthy Subjects
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of KPC000154 Tablets in Healthy Subjects
Participants needed: 92
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Kunming Pharmaceuticals, Inc.Updated: Mar 10, 2025Locations: 1
Eligibility criteria
Subjects must fully understand the purpose, nature, procedures of the trial, and... [+4]
Individuals with an allergic constitution (e.g., known allergies to two or more... [+26]